Economics and Financing of Vaccines for Diarrheal Diseases

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2014 Apr 24

PMID 24755623

Citations 4

Authors

Sarah M Bartsch

Bruce Y Lee

Affiliations

Soon will be listed here.

Abstract

The considerable burden of infectious disease-caused diarrhea around the world has motivated the continuing development of a number of vaccine candidates over the past several decades with some reaching the market. As with all major public health interventions, understanding the economics and financing of vaccines against diarrheal diseases is essential to their development and implementation. This review focuses on each of the major infectious pathogens that commonly cause diarrhea, the current understanding of their economic burden, the status of vaccine development, and existing economic evaluations of the vaccines. While the literature on the economics and financing of vaccines against diarrhea diseases is growing, there is considerable room for more inquiry. Substantial gaps exist for many pathogens, circumstances, and effects. Economics and financing studies are integral to vaccine development and implementation.

Citing Articles

Cost of Caregivers for Treating Hospitalized Diarrheal Patients in Bangladesh.

Sarker A, Sultana M, Ali N, Akram R, Alam K, Khan J Trop Med Infect Dis. 2018; 4(1).

PMID: 30587776 PMC: 6473641. DOI: 10.3390/tropicalmed4010005.

Economic costs of hospitalized diarrheal disease in Bangladesh: a societal perspective.

Sarker A, Sultana M, Mahumud R, Ali N, Huda T, Uzzaman M Glob Health Res Policy. 2018; 3:1.

PMID: 29318195 PMC: 5755417. DOI: 10.1186/s41256-017-0056-5.

Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy.

Hosangadi D, Smith P, Giersing B Vaccine. 2017; 37(50):7372-7380.

PMID: 29031690 PMC: 6892262. DOI: 10.1016/j.vaccine.2017.09.083.

Cost-effectiveness of norovirus vaccination in children in Peru.

Mirelman A, Ballard S, Saito M, Kosek M, Gilman R Vaccine. 2015; 33(27):3084-91.

PMID: 25980428 PMC: 4461495. DOI: 10.1016/j.vaccine.2015.05.004.

References

Tam C, Rodrigues L, Viviani L, Dodds J, Evans M, Hunter P . Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2011; 61(1):69-77. PMC: 3230829. DOI: 10.1136/gut.2011.238386. View

Fisman D, Chan C, Lowcock E, Naus M, Lee V . Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation. Vaccine. 2012; 30(52):7601-7. DOI: 10.1016/j.vaccine.2012.10.034. View

Poulos C, Riewpaiboon A, Stewart J, Clemens J, Guh S, Agtini M . Costs of illness due to endemic cholera. Epidemiol Infect. 2011; 140(3):500-9. PMC: 3824392. DOI: 10.1017/S0950268811000513. View

Widdowson M, Meltzer M, Zhang X, Bresee J, Parashar U, Glass R . Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics. 2007; 119(4):684-97. DOI: 10.1542/peds.2006-2876. View

Ghantoji S, Sail K, Lairson D, DuPont H, Garey K . Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010; 74(4):309-18. DOI: 10.1016/j.jhin.2009.10.016. View

Payne D, Vinje J, Szilagyi P, Edwards K, Staat M, Weinberg G . Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med. 2013; 368(12):1121-30. PMC: 4618551. DOI: 10.1056/NEJMsa1206589. View

Fischer Walker C, Sack D, Black R . Etiology of diarrhea in older children, adolescents and adults: a systematic review. PLoS Negl Trop Dis. 2010; 4(8):e768. PMC: 2914743. DOI: 10.1371/journal.pntd.0000768. View

Liu L, Johnson H, Cousens S, Perin J, Scott S, Lawn J . Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379(9832):2151-61. DOI: 10.1016/S0140-6736(12)60560-1. View

Fletcher S, Stark D, Harkness J, Ellis J . Enteric protozoa in the developed world: a public health perspective. Clin Microbiol Rev. 2012; 25(3):420-49. PMC: 3416492. DOI: 10.1128/CMR.05038-11. View

10.

Ziv T, Heymann A, Azuri J, Leshno M, Cohen D . Assessment of the underestimation of childhood diarrhoeal disease burden in Israel. Epidemiol Infect. 2010; 139(9):1379-87. DOI: 10.1017/S0950268810002554. View

11.

Gulland A . Simple measures could prevent more than two million child deaths from pneumonia and diarrhoea. BMJ. 2012; 344:e4025. DOI: 10.1136/bmj.e4025. View

12.

Jeuland M, Cook J, Poulos C, Clemens J, Whittington D . Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Value Health. 2009; 12(6):899-908. DOI: 10.1111/j.1524-4733.2009.00562.x. View

13.

Danial J, Cepeda J, Cameron F, Cloy K, Wishart D, Templeton K . Epidemiology and costs associated with norovirus outbreaks in NHS Lothian, Scotland 2007-2009. J Hosp Infect. 2011; 79(4):354-8. DOI: 10.1016/j.jhin.2011.06.018. View

14.

Patel M, Hall A, Vinje J, Parashar U . Noroviruses: a comprehensive review. J Clin Virol. 2008; 44(1):1-8. DOI: 10.1016/j.jcv.2008.10.009. View

15.

Werber D, Hille K, Frank C, Dehnert M, Altmann D, Muller-Nordhorn J . Years of potential life lost for six major enteric pathogens, Germany, 2004-2008. Epidemiol Infect. 2012; 141(5):961-8. PMC: 9151843. DOI: 10.1017/S0950268812001550. View

16.

Gastanaduy P, Hall A, Curns A, Parashar U, Lopman B . Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. J Infect Dis. 2013; 207(7):1058-65. DOI: 10.1093/infdis/jis942. View

17.

. Cholera, 2012. Wkly Epidemiol Rec. 2013; 88(31):321-334. View

18.

van Hoek A, Ngama M, Ismail A, Chuma J, Cheburet S, Mutonga D . A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines. PLoS One. 2012; 7(10):e47511. PMC: 3480384. DOI: 10.1371/journal.pone.0047511. View

19.

Lee B, Assi T, Rajgopal J, Norman B, Chen S, Brown S . Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger. Am J Public Health. 2011; 102(2):269-76. PMC: 3386610. DOI: 10.2105/AJPH.2011.300218. View

20.

Hall A, Rosenthal M, Gregoricus N, Greene S, Ferguson J, Henao O . Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005. Emerg Infect Dis. 2011; 17(8):1381-8. PMC: 3381564. DOI: 10.3201/eid1708.101533. View